cloudfront

Report Detail



OtherGlobal RNAi Technologies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541269
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 117 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global RNAi Technologies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 RNAi Technologies Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Oncology
  • 1.2.2 Ocular disorders
  • 1.2.3 Respiratory disorders
  • 1.2.4 Liver diseases
  • 1.2.5 Other
  • 1.3 Market Analysis by Applications
  • 1.3.1 Research
  • 1.3.2 Therapeutics
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Alnylam Pharmaceuticals
    • 2.1.1 Business Overview
  • 2.1.2 RNAi Technologies Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Alnylam Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Benitec Biopharma Ltd
  • 2.2.1 Business Overview
  • 2.2.2 RNAi Technologies Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Benitec Biopharma Ltd RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Filmtec Corporation
  • 2.3.1 Business Overview
  • 2.3.2 RNAi Technologies Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Filmtec Corporation RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Ionis Pharmaceuticals
  • 2.4.1 Business Overview
  • 2.4.2 RNAi Technologies Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Ionis Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Quark Pharmaceuticals Inc.
  • 2.5.1 Business Overview
  • 2.5.2 RNAi Technologies Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 RXI Pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 RNAi Technologies Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 RXI Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Qiagen
  • 2.7.1 Business Overview
  • 2.7.2 RNAi Technologies Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Qiagen RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Invitrogen
  • 2.8.1 Business Overview
  • 2.8.2 RNAi Technologies Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Invitrogen RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Ambion
  • 2.9.1 Business Overview
  • 2.9.2 RNAi Technologies Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Ambion RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global RNAi Technologies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global RNAi Technologies Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global RNAi Technologies Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 RNAi Technologies Manufacturer Market Share in 2017
  • 3.3.2 Top 6 RNAi Technologies Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global RNAi Technologies Market Analysis by Regions

    • 4.1 Global RNAi Technologies Sales, Revenue and Market Share by Regions
    • 4.1.1 Global RNAi Technologies Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global RNAi Technologies Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America RNAi Technologies Sales and Growth Rate (2013-2018)
  • 4.3 Europe RNAi Technologies Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific RNAi Technologies Sales and Growth Rate (2013-2018)
  • 4.5 South America RNAi Technologies Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa RNAi Technologies Sales and Growth Rate (2013-2018)
  • 5 North America RNAi Technologies by Countries

    • 5.1 North America RNAi Technologies Sales, Revenue and Market Share by Countries
    • 5.1.1 North America RNAi Technologies Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America RNAi Technologies Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States RNAi Technologies Sales and Growth Rate (2013-2018)
  • 5.3 Canada RNAi Technologies Sales and Growth Rate (2013-2018)
  • 5.4 Mexico RNAi Technologies Sales and Growth Rate (2013-2018)
  • 6 Europe RNAi Technologies by Countries

    • 6.1 Europe RNAi Technologies Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe RNAi Technologies Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe RNAi Technologies Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany RNAi Technologies Sales and Growth Rate (2013-2018)
  • 6.3 UK RNAi Technologies Sales and Growth Rate (2013-2018)
  • 6.4 France RNAi Technologies Sales and Growth Rate (2013-2018)
  • 6.5 Russia RNAi Technologies Sales and Growth Rate (2013-2018)
  • 6.6 Italy RNAi Technologies Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific RNAi Technologies by Countries

    • 7.1 Asia-Pacific RNAi Technologies Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific RNAi Technologies Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific RNAi Technologies Revenue and Market Share by Countries (2013-2018)
  • 7.2 China RNAi Technologies Sales and Growth Rate (2013-2018)
  • 7.3 Japan RNAi Technologies Sales and Growth Rate (2013-2018)
  • 7.4 Korea RNAi Technologies Sales and Growth Rate (2013-2018)
  • 7.5 India RNAi Technologies Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia RNAi Technologies Sales and Growth Rate (2013-2018)
  • 8 South America RNAi Technologies by Countries

    • 8.1 South America RNAi Technologies Sales, Revenue and Market Share by Countries
    • 8.1.1 South America RNAi Technologies Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America RNAi Technologies Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil RNAi Technologies Sales and Growth Rate (2013-2018)
  • 8.3 Argentina RNAi Technologies Sales and Growth Rate (2013-2018)
  • 8.4 Colombia RNAi Technologies Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa RNAi Technologies by Countries

    • 9.1 Middle East and Africa RNAi Technologies Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa RNAi Technologies Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa RNAi Technologies Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia RNAi Technologies Sales and Growth Rate (2013-2018)
  • 9.3 UAE RNAi Technologies Sales and Growth Rate (2013-2018)
  • 9.4 Egypt RNAi Technologies Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria RNAi Technologies Sales and Growth Rate (2013-2018)
  • 9.6 South Africa RNAi Technologies Sales and Growth Rate (2013-2018)
  • 10 Global RNAi Technologies Market Segment by Type

    • 10.1 Global RNAi Technologies Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global RNAi Technologies Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global RNAi Technologies Revenue and Market Share by Type (2013-2018)
  • 10.2 Oncology Sales Growth and Price
  • 10.2.1 Global Oncology Sales Growth (2013-2018)
  • 10.2.2 Global Oncology Price (2013-2018)
  • 10.3 Ocular disorders Sales Growth and Price
  • 10.3.1 Global Ocular disorders Sales Growth (2013-2018)
  • 10.3.2 Global Ocular disorders Price (2013-2018)
  • 10.4 Respiratory disorders Sales Growth and Price
  • 10.4.1 Global Respiratory disorders Sales Growth (2013-2018)
  • 10.4.2 Global Respiratory disorders Price (2013-2018)
  • 10.5 Liver diseases Sales Growth and Price
  • 10.5.1 Global Liver diseases Sales Growth (2013-2018)
  • 10.5.2 Global Liver diseases Price (2013-2018)
  • 10.6 Other Sales Growth and Price
  • 10.6.1 Global Other Sales Growth (2013-2018)
  • 10.6.2 Global Other Price (2013-2018)
  • 11 Global RNAi Technologies Market Segment by Application

    • 11.1 Global RNAi Technologies Sales Market Share by Application (2013-2018)
    • 11.2 Research Sales Growth (2013-2018)
    • 11.3 Therapeutics Sales Growth (2013-2018)

    12 RNAi Technologies Market Forecast (2018-2023)

    • 12.1 Global RNAi Technologies Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 RNAi Technologies Market Forecast by Regions (2018-2023)
    • 12.2.1 North America RNAi Technologies Market Forecast (2018-2023)
  • 12.2.2 Europe RNAi Technologies Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific RNAi Technologies Market Forecast (2018-2023)
  • 12.2.4 South America RNAi Technologies Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa RNAi Technologies Market Forecast (2018-2023)
  • 12.3 RNAi Technologies Market Forecast by Type (2018-2023)
  • 12.3.1 Global RNAi Technologies Sales Forecast by Type (2018-2023)
  • 12.3.2 Global RNAi Technologies Market Share Forecast by Type (2018-2023)
  • 12.4 RNAi Technologies Market Forecast by Application (2018-2023)
  • 12.4.1 Global RNAi Technologies Sales Forecast by Application (2018-2023)
  • 12.4.2 Global RNAi Technologies Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.

      Scope of the Report:

      The worldwide market for RNAi Technologies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the RNAi Technologies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Alnylam Pharmaceuticals

      Benitec Biopharma Ltd

      Filmtec Corporation

      Ionis Pharmaceuticals

      Quark Pharmaceuticals Inc.

      RXI Pharmaceuticals

      Qiagen

      Invitrogen

      Ambion

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Oncology

      Ocular disorders

      Respiratory disorders

      Liver diseases

      Other

      Market Segment by Applications, can be divided into

      Research

      Therapeutics

      There are 15 Chapters to deeply display the global RNAi Technologies market.

      Chapter 1, to describe RNAi Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of RNAi Technologies, with sales, revenue, and price of RNAi Technologies, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of RNAi Technologies, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, RNAi Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe RNAi Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on RNAi Technologies . Industry analysis & Market Report on RNAi Technologies is a syndicated market report, published as Global RNAi Technologies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of RNAi Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report